Reporting of Cardiovascular Events in Clinical Trials Supporting FDA Approval of Contemporary Cancer Therapies

BACKGROUND: Cardiovascular disease (CVD) has become an increasingly common limitation to effective anticancer therapy. Yet, whether CVD events were consistently reported in pivotal trials supporting contemporary anticancer drugs is unknown. OBJECTIVES: The authors sought to evaluate the incidence, c...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Am Coll Cardiol
Main Authors: Bonsu, Janice M., Guha, Avirup, Charles, Lawrence, Yildiz, Vedat O., Wei, Lai, Baker, Brandee, Brammer, Jonathan E., Awan, Farrukh, Lustberg, Maryam, Reinbolt, Raquel, Miller, Eric D., Jneid, Hani, Ruz, Patrick, Carter, Rebecca R., Milks, Michael W., Paskett, Electra D., Addison, Daniel
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7860639/
https://ncbi.nlm.nih.gov/pubmed/32057377
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jacc.2019.11.059
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados